Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Surgery Today
Published in: Surgery Today 9/2016

01-09-2016 | Original Article

Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer

Authors: Satoru Ishii, Keishi Yamashita, Hiroshi Kato, Nobuyuki Nishizawa, Hideki Ushiku, Hiroaki Mieno, Hiromitu Moriya, Kei Hosoda, Natuya Katada, Shiro Kikuchi, Satoshi Tanabe, Wasaburo Koizumi, Makoto Saegusa, Masahiko Watanabe

Published in: Surgery Today | Issue 9/2016

Login to get access

Abstract

Purpose

Endoscopic therapy for clinical T1aN0 (cT1aN0) gastric cancer is an excellent therapeutic strategy; however, pathological lymph node metastasis (LNM) occasionally occurs. Patients who have a potential for LNM are subject to additional gastrectomy. Our aim was to identify predictors of LNM in additional gastrectomy.

Methods

One hundred and twelve cT1aN0 gastric cancer patients undergoing additional gastrectomy after endoscopic resection were identified between 1997 and 2013. Predictors for LNM were initially selected by a univariate analysis and applied to a multivariate analysis.

Results

(1) Twelve patients (10.7 %) had LNM following additional gastrectomy. (2) Clinicopathological factors significantly associated with LNM were the depth of invasion (SM2 or deeper, designated as SM2) (p = 0.0018) and rigorous lymphatic invasion (ly2,3) (p < 0.001). (3) The univariate predictors for LNM were applied to the multivariate logistic regression model, and SM2 (p = 0.0027) and ly2,3 (p = 0.0028) remained significant predictors. (4) When classified into 2 × 2 subgroups, the predictability for LNM was as follows: SM2 plus ly2,3 (46.7 %), SM2 plus ly0,1 (10.0 %), M,SM1 plus ly2,3 (0 %), and M,SM1 plus ly0,1 (0 %).

Conclusions

In cT1aN0 gastric cancer patients, both SM2 and ly2,3 are significant predictors for LNM that may be important as references for additional gastrectomy after endoscopic resection.
Appendix
Available only for authorised users
Literature
1.
Park CH, Shin S, Park JC, Shin SK, Lee SK, Lee YC, et al. Long-term outcome of early gastric cancer after endoscopic submucosal dissection : expanded indication is comparable to absolute indication. Dig Liver Dis. 2013;45:651–6.CrossRefPubMed
2.
Takayama T, Matsumoto S, Wakatsuki K, Tanaka K, Migita K, Ito M, et al. A novel laparoscopic procedure for treating proximal early gastric cancer: laparoscopy-assisted pylorus-preserving nearly total gastrectomy. Surg Today. 2014;44:2332–8.CrossRefPubMed
3.
Takiguchi S, Fujiwara Y, Yamasaki M, Miyata H, Nakajima K, Nishida T, et al. Laparoscopic intraoperative navigation surgery for gastric cancer using real-time rendered 3D CT images. Surg Today. 2015;45:618–24.CrossRefPubMed
4.
Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y, Shimoda T, et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer. 2000;3:219–25.CrossRefPubMed
5.
Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer. 2011;14:113–23.CrossRef
6.
Roviello F, Rossi S, Marrelli D, Pedrazzani C, Corso G, Vindigni C, et al. Number of lymph node metastases and its prognostic significance in early gastric cancer: a multicenter Italian study. J Surg Oncol. 2006;94:275–80 (discussion 274).CrossRefPubMed
7.
Kim DY, Joo JK, Ryu SY, Kim YJ, Kim SK. Factors related to lymph node metastasis and surgical strategy used to treat early gastric carcinoma. World J Gastroenterol. 2004;10:737–40.CrossRefPubMedPubMedCentral
8.
Sano T, Sasako M, Kinoshita T, Maruyama K. Recurrence of early gastric cancer. Follow-up of 1475 patients and review of Japanese literature. Cancer. 1993;72(11):3174–8.CrossRefPubMed
9.
Maruyama K, Gunven P, Okabayashi K, Sasako M, Kinoshita T. Lymph node metastases of gastric cancer. General pattern in 1931 patients. Ann Surg. 1989;210(5):596–602.CrossRefPubMedPubMedCentral
10.
Oda I, Gotoda T, Sasako M, Sano T, Katai H, Fukagawa T, et al. Treatment strategy after non-curative endoscopic resection of early gastric cancer. Br J Surg. 2008;95:1495–500.CrossRefPubMed
11.
Kusano C, Iwasaki M, Kaltenbach T, Conlin A, Oda I, Gotoda T. Should elderly patients undergo additional surgery after non-curative endoscopic resection for early gastric cancer? Long-term comparative outcomes. Am J Gastroenterol. 2011;106:1064–9.CrossRefPubMed
12.
Kakushima N, Hagiwara T, Tanaka M, Sawai H, Kawata N, Takizawa K, et al. Endoscopic submucosal dissection for early gastric cancer in cases preoperatively contraindicated for endoscopic treatment. United European Gastroenterol J. 2013;1:453–60.CrossRefPubMedPubMedCentral
13.
Ryu KW, Choi IJ, Doh YW, Kook MC, Kim CG, Park HJ, et al. Surgical indication for non-curative endoscopic resection in early gastric cancer. Ann Surg Oncol. 2007;14:3428–34.CrossRefPubMed
14.
Ito H, Inoue H, Ikeda H, Odaka N, Yoshida A, Satodate H, et al. Surgical outcomes and clinicopathological characteristics of patients who underwent potentially noncurative endoscopic resection for gastric cancer. A report of singlr-center experience. Gstroenterol Res Pract. 2013;2013:427405.
15.
Son SY, Park JY, Ryu KW, Eom BW, Yoon HM, Cho SJ, et al. The risk factors for lymph node metastasis in early gastric cancer patients who underwent endoscopic resection: in the minimal lymph node dissection applicable? A retrospective study. Surg Endosc. 2013;27:3247–53.CrossRefPubMed
16.
Song KY, Hyung WJ, Kim HH, Han SU, Cho GS, Ryu SW, et al. Is gastrectomy mandatory for all residual or recurrent gastric cancer following endoscopic resection? A large-scale Korean multi-center study. J Surg Oncol. 2008;98:6–10.CrossRefPubMed
17.
Ren G, Cai R, Zhang WJ, Ou JM, Jin YN, Li WH. Prediction of risk factors for lymph node metastasis in early gastric cancer. World J Gastroenterol. 2013;19(20):3096–107.CrossRefPubMedPubMedCentral
18.
Yang HJ, Kim SG, Lim JH, Choi J, Im JP, Kim JS, et al (2014) Predictors of lymph node metastasis in patients with non-curative endoscopic resection of early gastric cancer. Surg Endosc (epub ahead of print).
19.
Fujii M, Egashira Y, Akutagawa H, Nishida T, Nitta T, Edagawa G, et al. Pathological factors related to lymph node metastasis of submucosally invasive gastric cancer: criteria for additional gastrectomy after endoscopic resection. Gastric Cancer. 2013;16:521–30.CrossRefPubMed
20.
Kim H, Kim JH, Park JC, Lee YC, Noh SH, Kim H. Lympho-vascular invasion is an important predictor of lymph node metastasis in endoscopically resected early gastric cancer. Oncol Rep. 2011;25:1589–95.PubMed
21.
Kwee RM, Kwee TC. Predicting lymph node status in early gastric cancer. Gastric Cancer. 2008;11:134–48.CrossRefPubMed
22.
Kurokawa Y, Hasuike N, Ono H, Boku N, Fukuda H. A, Phase II, trial of endoscopic submucosal dissection for mucosal gastric cancer. Japan Clinical Oncology Group Study JCOG0607. Jpn J Clin Oncol. 2009;39(7):464–6.CrossRefPubMed
23.
Japanese Gastric Cancer Association. Japanese classification of gastric cancer: 3rd edition. Gastric Cancer. 2011;14:101–12.CrossRef
24.
Nakamura Y, Yasuoka H, Tsujimoto M, Kurozumi K, Nakahara M, Nakao K, et al. Importance of lymph vessels in gastric cancer: a prognostic indicator in general and a predictor for lymph node metastasis in early gastric cancer. J Clin Pathol. 2006;59:77–82.CrossRefPubMedPubMedCentral
25.
Araki I, Hosoda K, Yamashita K, Katada N, Sakuramoto S, Moriya H, et al. Prognostic impact of venous invasion in stage IB node-negative gastric cancer. Gastric Cancer. 2015;18:297–305.CrossRefPubMed
26.
Bosman FT, Carneiro F, Hruban RH, Theise ND. WHO classification of tumors of the digestive system. 4th ed. Lyon: International Agency for Research on Cancer; 2010.
27.
Choi J, Kim SG, Im JP, Kim JS, Jung HC, Song IS. Comparison of endoscopic ultrasonography and conventional endoscopy for prediction of depth of tumor invasion in early gastric cancer. Endoscopy. 2010;42:705–13.CrossRefPubMed
28.
Shida A, Fujioka S, Kawamura M, Takahashi N, Ishibashi Y, Nakada K, et al. Prediction of lymph node metastasis in patients with submucosa-invading early gastric cancer. Anticancer Res. 2014;34:4471–4.PubMed
Metadata
Title
Predictive factors for lymph node metastasis in additional gastrectomy after endoscopic resection of cT1aN0 gastric cancer
Authors
Satoru Ishii
Keishi Yamashita
Hiroshi Kato
Nobuyuki Nishizawa
Hideki Ushiku
Hiroaki Mieno
Hiromitu Moriya
Kei Hosoda
Natuya Katada
Shiro Kikuchi
Satoshi Tanabe
Wasaburo Koizumi
Makoto Saegusa
Masahiko Watanabe
Publication date
01-09-2016
Publisher
Springer Japan
Published in
Surgery Today / Issue 9/2016
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI
https://doi.org/10.1007/s00595-015-1281-5

Other articles of this Issue 9/2016

Surgery Today 9/2016 Go to the issue

Original Article

Preliminary study on liver function changes after trisectionectomy with versus without prior portal vein embolization

Original Article

Clinical results of endovenous LASER ablation (EVLA) using low linear endovenous energy density (LEED) combined with high ligation for great saphenous varicose veins

Original Article

Glucagon-like peptide-1 prevented abdominal aortic aneurysm development in rats

Review Article

DNA damage response and sphingolipid signaling in liver diseases

Review Article

Overview of current surgical strategies for aortic disease in patients with Marfan syndrome

Original Article

A perioperative strategy for abdominal aortic aneurysm in patients with chronic renal insufficiency